Skip to main navigation Skip to search Skip to main content

Successful cyclophosphamide treatment of cryoglobulinemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection

  • Richard J. Quigg
  • , Michel Brathwaite
  • , David F. Gardner
  • , David R. Gretch
  • , Shaun Ruddy
  • Virginia Commonwealth University
  • University of Washington

Research output: Contribution to journalArticlepeer-review

43 Scopus citations

Abstract

A 54-year-old man with cryoglobulinemia and chronic hepatitis C infection presented with progressive renal insufficiency caused by membranoproliferative glomerulonephritis. Because of a steady decline in renal function, cyclophosphamide therapy was instituted. Within 1 month of starting therapy, his cryoglobulins disappeared, and in 3 months, his creatinine clearance had improved from 56 mL/min to 89 mL/min. At no point in his course was there clinical evidence of liver disease. After 1 year, cyclophosphamide was successfully stopped. Fourteen months later, his creatinine clearance is 105 mL/min. These results suggest that cyclophosphamide may be useful therapy for patients with cryoglobulinemic membranoproliferative glomerulonephritis and hepatitis C virus infection who have progressive renal insufficiency.

Original languageEnglish
Pages (from-to)798-800
Number of pages3
JournalAmerican Journal of Kidney Diseases
Volume25
Issue number5
DOIs
StatePublished - May 1995

Keywords

  • cryoglobulinemia
  • hepatitis C
  • Membranoproliferative glomerulonephritis
  • therapy

Fingerprint

Dive into the research topics of 'Successful cyclophosphamide treatment of cryoglobulinemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection'. Together they form a unique fingerprint.

Cite this